Pharmacy & Therapeutics- August 2008 - (Page 473)

Now Available TM For more information, visit www.RELISTOR.com © 2008, Wyeth Pharmaceuticals Inc., Philadelphia, PA 19101 218615-01 http://www.RELISTOR.com http://www.RELISTOR.com Table of Contents for the Digital Edition of Pharmacy & Therapeutics- August 2008Pharmacy & Therapeutics- August 2008ContentsEditorialMedication ErrorsPrescription: WashingtonNew Drugs/Drug News/ New Medical DevicesDrug ForecastMonitoring Asthma Control Using Claims Data and Patient-Reported Outcomes MeasuresLow-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe SepsisAmerican Society of HypertensionThe Pharmacological Management of Migraine, Part 2CE Test and FormsPharmacy & Therapeutics- August 2008Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page Cover)Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page Welcome)Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page 427)Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page 428)Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page 429)Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page 430)Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page 431)Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page 432)Pharmacy & Therapeutics- August 2008 - Pharmacy & Therapeutics- August 2008 (Page 433)Pharmacy & Therapeutics- August 2008 - Contents (Page 434)Pharmacy & Therapeutics- August 2008 - Contents (Page 435)Pharmacy & Therapeutics- August 2008 - Contents (Page 436)Pharmacy & Therapeutics- August 2008 - Contents (Page 437)Pharmacy & Therapeutics- August 2008 - Editorial (Page 438)Pharmacy & Therapeutics- August 2008 - Editorial (Page 439)Pharmacy & Therapeutics- August 2008 - Editorial (Page 440)Pharmacy & Therapeutics- August 2008 - Medication Errors (Page 441)Pharmacy & Therapeutics- August 2008 - Prescription: Washington (Page 442)Pharmacy & Therapeutics- August 2008 - New Drugs/Drug News/ New Medical Devices (Page 443)Pharmacy & Therapeutics- August 2008 - New Drugs/Drug News/ New Medical Devices (Page 444)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 445)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 446)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 447)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 448)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 449)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 450)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 451)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 452)Pharmacy & Therapeutics- August 2008 - Drug Forecast (Page 453)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 454)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 455)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 456)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 457)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 458)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 459)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 460)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 461)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 462)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 463)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 464)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 465)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 466)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 467)Pharmacy & Therapeutics- August 2008 - Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures (Page 468)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 469)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 470)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 471)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 472)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 473)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 474)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 475)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 476)Pharmacy & Therapeutics- August 2008 - Low-Dose, Off-Label Drotrecogin Alfa (Xigris) In Severe Sepsis (Page 477)Pharmacy & Therapeutics- August 2008 - American Society of Hypertension (Page 478)Pharmacy & Therapeutics- August 2008 - American Society of Hypertension (Page 479)Pharmacy & Therapeutics- August 2008 - The Pharmacological Management of Migraine, Part 2 (Page 480)Pharmacy & Therapeutics- August 2008 - The Pharmacological Management of Migraine, Part 2 (Page 481)Pharmacy & Therapeutics- August 2008 - The Pharmacological Management of Migraine, Part 2 (Page 482)Pharmacy & Therapeutics- August 2008 - The Pharmacological Management of Migraine, Part 2 (Page 483)Pharmacy & Therapeutics- August 2008 - The Pharmacological Management of Migraine, Part 2 (Page 484)Pharmacy & Therapeutics- August 2008 - The Pharmacological Management of Migraine, Part 2 (Page 485)Pharmacy & Therapeutics- August 2008 - The Pharmacological Management of Migraine, Part 2 (Page 486)Pharmacy & Therapeutics- August 2008 - The Pharmacological Management of Migraine, Part 2 (Page 487)Pharmacy & Therapeutics- August 2008 - CE Test and Forms (Page 488)Pharmacy & Therapeutics- August 2008 - CE Test and Forms (Page 489)Pharmacy & Therapeutics- August 2008 - CE Test and Forms (Page 490)Pharmacy & Therapeutics- August 2008 - CE Test and Forms (Page 491)Pharmacy & Therapeutics- August 2008 - CE Test and Forms (Page 492)http://www.nxtbook.com/nxtbooks/medimedia/pt_200911http://www.nxtbook.com/nxtbooks/medimedia/pt_200910http://www.nxtbook.com/nxtbooks/medimedia/pt_200909http://www.nxtbook.com/nxtbooks/medimedia/pt_200908http://www.nxtbook.com/nxtbooks/medimedia/pt_200907http://www.nxtbook.com/nxtbooks/medimedia/pt_200906http://www.nxtbook.com/nxtbooks/medimedia/pt_200905http://www.nxtbook.com/nxtbooks/medimedia/pt_200904http://www.nxtbook.com/nxtbooks/medimedia/pt_200903http://www.nxtbook.com/nxtbooks/medimedia/pt_200902http://www.nxtbook.com/nxtbooks/medimedia/pt_200901http://www.nxtbook.com/nxtbooks/medimedia/pt_200812http://www.nxtbook.com/nxtbooks/medimedia/pt_200811http://www.nxtbook.com/nxtbooks/medimedia/pt_200810http://www.nxtbook.com/nxtbooks/medimedia/pt_200809http://www.nxtbook.com/nxtbooks/medimedia/pt_200808http://www.nxtbook.com/nxtbooks/medimedia/pt_200807http://www.nxtbook.com/nxtbooks/medimedia/pt_200806http://www.nxtbook.com/nxtbooks/medimedia/pt_200805http://www.nxtbook.com/nxtbooks/medimedia/pt_200804http://www.nxtbook.com/nxtbooks/medimedia/pt_200803http://www.nxtbook.com/nxtbooks/medimedia/pt_200802http://www.nxtbook.com/nxtbooks/medimedia/pt_200801http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.